a global effort to create the foundation for

preventive
care

initiated by

initiated by

coordinated by

coordinated by

⸻ CHALLENGE / 01

A response to a global crisis

Chronic non-communicable diseases (NCDs) are the world's leading cause of death
— and its defining economic challenge.

>41M

Global NCD
deaths/year*

>18M

Premature deaths
(age under 70)*

75%

Deaths
due to NCDs*

>$47T

Estimated global economic
impact by 2030**

* World Health Organization (WHO), 2025
** World Economic Forum, 2023

⸻ APPROACH / 02

Your health
is not average

Most diagnostic tests compare you to a population range. protecting.health compares you to yourself — building a personal molecular baseline that reveals early deviations before symptoms emerge.

step 1

Follow people
over time

Repeated health data and blood samples create each person’s molecular baseline.

step 2

Molecular phenotyping

Advanced platforms measure signals that may shift before symptoms appear.

step 3

Build early
screening tools

AI helps identify patterns linked to the risk or onset of major chronic diseases.

⸻ FRAMEWORK / 03

A global collaboration
built on local clinical
excellence

step 1

Local Clinical
Study Centers

Each partner establishes its
own center and clinical
cohort.

step 2

Central Molecular Phenotyping Center

Partners send samples and pseudonymized health data for standardized molecular phenotyping

step 3

PH 1.0
Development

Integrated multi-partner data is used to build the PH1.0 health screening algorithm.

step 4

Shared Scientific & Commercial alue

Partners share the commercial value of PH1.0 and related outputs based on their contributions.

⸻ PROGRAMME OUTPUTS / 04

A biobank, a dataset &
an algorithm

Longitudinal biobank

500,000

Longitudinal blood samples over 10 years from 40K participants

Deep phenotyped data

 4000+ 

Molecular variables measured longitudinally

Algorithm & IP

 PH 1.0 

A personalised health screening algorithm—designed for clinical use

⸻ GET INVOLVED / 05

Let’s develop
personalize
preventive medicine
together

For research institutions, clinical partners, and technology collaborators to join the initiative.

For sponsors and investors with passion for benefiting humankind.